Velano Vascular Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 29

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Velano Vascular General Information

Description

Developer of a needle-free blood collection medical device designed to reduce the risk and inefficiencies of vascular access practices. The company's device is a single-use and sterile device that temporarily attaches to a peripheral IV catheter to collect a fresh venous sample to combat the urgent challenge of vascular access, enabling hospitals to deliver painless and secure healthcare procedures for patients.

Contact Information

Formerly Known As
Creative Vascular
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 221 Pine Street
  • Suite 200
  • San Francisco, CA 94104
  • United States
Primary Industry
Medical Supplies
Acquirer
Becton, Dickinson and Company
Vertical(s)
Corporate Office
  • 221 Pine Street
  • Suite 200
  • San Francisco, CA 94104
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Velano Vascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 20-Jul-2021 Completed Out of Business
10. Accelerator/Incubator 23-Aug-2017 Completed Generating Revenue
9. Debt - PPP 15-Apr-2020 Completed Generating Revenue
8. Later Stage VC 03-Jan-2020 Completed Generating Revenue
7. Later Stage VC (Series B1) 08-May-2019 Completed Generating Revenue
6. Later Stage VC (Series B) 07-Mar-2017 Completed Generating Revenue
5. Early Stage VC (Series A2) 08-Feb-2016 Completed Generating Revenue
4. Early Stage VC (Series A1) 01-Jan-2015 Completed Startup
3. Grant 27-Oct-2014 $50K $2.6M Completed Startup
2. Early Stage VC (Series A) 01-Nov-2013 $2.45M $2.6M Completed Startup
To view Velano Vascular’s complete valuation and funding history, request access »

Velano Vascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
Series B
Series A2
Series A1 446,177 $0.000100 6% $5.6 $5.6 1x $5.6 7.89%
Series A 828,521 $0.000100 6% $2.96 $2.96 1x $2.96 14.66%
To view Velano Vascular’s complete cap table history, request access »

Velano Vascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a needle-free blood collection medical device designed to reduce the risk and inefficiencies of vascular ac
Medical Supplies
San Francisco, CA
29 As of 2021

Seattle, WA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Velano Vascular Competitors (5)

One of Velano Vascular’s 5 competitors is Tasso, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tasso Venture Capital-Backed Seattle, WA
Spot On Sciences Private Equity-Backed San Francisco, CA
YourBio Health Formerly VC-backed Medford, MA
HemaXis Venture Capital-Backed Gland, Switzerland
Vortex Biosciences Venture Capital-Backed Manchester, United Kingdom
You’re viewing 5 of 5 competitors. Get the full list »

Velano Vascular Patents

Velano Vascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020333843-A1 Fluid transfer devices with extended length catheters and methods of using the same Active 20-Aug-2019
AU-2020333843-B2 Fluid transfer devices with extended length catheters and methods of using the same Active 20-Aug-2019
CA-3151924-A1 Fluid transfer devices with extended length catheters and methods of using the same Pending 20-Aug-2019
EP-4017571-A1 Fluid transfer devices with extended length catheters and methods of using the same Pending 20-Aug-2019
EP-4017571-A4 Fluid transfer devices with extended length catheters and methods of using the same Pending 20-Aug-2019 A61M25/01
To view Velano Vascular’s complete patent history, request access »

Velano Vascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Velano Vascular Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
D-W Investments Real Estate Minority
Eastward Capital Partners Venture Capital Minority
Angel (individual) Minority
First Round Capital Venture Capital Minority
Griffin Hospital Corporation Minority
You’re viewing 5 of 17 investors. Get the full list »

Velano Vascular FAQs

  • When was Velano Vascular founded?

    Velano Vascular was founded in 2012.

  • Where is Velano Vascular headquartered?

    Velano Vascular is headquartered in San Francisco, CA.

  • What is the size of Velano Vascular?

    Velano Vascular has 29 total employees.

  • What industry is Velano Vascular in?

    Velano Vascular’s primary industry is Medical Supplies.

  • Is Velano Vascular a private or public company?

    Velano Vascular is a Private company.

  • What is Velano Vascular’s current revenue?

    The current revenue for Velano Vascular is .

  • How much funding has Velano Vascular raised over time?

    Velano Vascular has raised $61.8M.

  • Who are Velano Vascular’s investors?

    D-W Investments, Eastward Capital Partners, , First Round Capital, and Griffin Hospital are 5 of 17 investors who have invested in Velano Vascular.

  • Who are Velano Vascular’s competitors?

    Tasso, Spot On Sciences, YourBio Health, HemaXis, and Vortex Biosciences are competitors of Velano Vascular.

  • When was Velano Vascular acquired?

    Velano Vascular was acquired on 20-Jul-2021.

  • Who acquired Velano Vascular?

    Velano Vascular was acquired by Becton, Dickinson and Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process